default author photo

Markus Moehler

Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik

Mainz

Germany

SCHOLARLY PAPERS

2

DOWNLOADS

98

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

FOLFIRI with Cetuximab or Bevacizumab in RAS Wild-Type Metastatic Colorectal Cancer: Refining First-Line Treatment Selection by Combining Clinical Parameters - A post hoc Analysis of the Randomized Open-Label Phase III Trial FIRE-3/AIO KRK0306

Number of pages: 25 Posted: 20 Feb 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, Charité–Universitätsmedizin Berlin, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Charité–Universitätsmedizin Berlin, Gesundheitszentrum St. Marien, HOPE—Practice for Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Rostock - Rostock University Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik, Charité–Universitätsmedizin Berlin, University of Melbourne and LMU Munich - Department of Hematology/Oncology
Downloads 68 (891,180)

Abstract:

Loading...

metastatic colorectal cancer, primary tumor sidedness, metastatic pattern, liver-limited disease, predictive biomarker, biomarker combination, comprehensive statisticalmodelling, FOLFIRI, cetuximab, bevacizumab

2.

Cisplatin and 5-Fluorouracil with or Without Epidermal Growth Factor Receptor Inhibition Panitumumab for Patients with Non-Resectable, Advanced or Metastatic Esophageal Squamous Cell Cancer: A Prospective, Open-Label, Randomised Phase 3 AIO/EORTC Trial (Power)

Number of pages: 31 Posted: 17 Apr 2019
Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik, Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik, Charité - Universitätsmedizin Berlin, Tel Aviv University - Sackler Faculty of Medicine, University of Duisburg-Essen - University Hospital Essen, University Hospital Ulm, University of Mannheim, Krankenhaus Nordwest General Hospital - Institute of Clinical Cancer Research (ICCR), Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology, Onkologie Leer-Emden-Papenburg, Caritas Klinikum, University of Leipzig - Faculty of Medicine, Autonomous University of Barcelona - Institute of Oncology (VHIO), University of Rostock - University Medicine Rostock (UMR), Paracelsus Medical University Salzburg, Medical University of Innsbruck, Johannes Gutenberg University Mainz, Technische Universität München (TUM) - Institute of Pathology, KU Leuven and Technische Universität München (TUM)
Downloads 30 (1,318,317)
Citation 2

Abstract:

Loading...

esophageal squamous cell cancer, panitumumab, EGFR, palliative chemotherapy, cisplatin, 5-fluorouracil